UPDATE : Saturday, October 12, 2019
상단여백
New way found to heal wounds of autoimmune disease patients by Song Soo-youn 2019-08-28 15:19
‘GI Innovation will be small but strong leader of bioindustry’ by Kim Yun-mi 2019-08-27 15:57
Invossa victims, Kolon shareholders demand apology, compensation by Jeong Sae-im 2019-08-27 15:40
Regulator decides to delist Kolon TissueGene by Jeong Sae-im 2019-08-27 12:15
Medipost’s Pneumostem gets FDA’s fast-track designation by Lee Han-soo 2019-08-23 17:51
라인
GenNBio to test transplanting pig’s pancreatic islet into human next year by Jeong Sae-im 2019-08-23 13:53
Japan gives further nod to Celltrion's breast cancer biosimilar by Lee Han-soo 2019-08-22 16:47
Pharmicell submits new drug application for ovarian cancer treatment by Lee Han-soo 2019-08-19 13:10
Stock exchange names Kolon Life Science as administrative issue by Lee Han-soo 2019-08-16 16:49
Medipost’s stem cell therapy, cord blood bank show solid growth by Jeong Sae-im 2019-08-16 16:18
라인
CHA Biotech wins patent for placenta-derived mesenchymal stem cells by Lee Han-soo 2019-08-12 18:24
Samsung BioLogics implants cell-culturing tech by Lee Han-soo 2019-08-12 16:05
Injectable hydrogels developed to raise stem cell survival rate by Song Soo-youn 2019-08-12 15:18
HLB to seek pre-NDA meeting with FDA for rivoceranib by Jeong Sae-im 2019-08-06 15:43
Roche, MSD, AstraZeneca: top 3 risers on NASDAQ biotech by Kim Yun-mi 2019-08-06 11:29
라인
Pharmicell submits investigational new drug application for prostate cancer treatment by Lee Han-soo 2019-08-05 17:59
Sillajen’s trouble heralds fall of one of most prominent biotech firms by Lee Han-soo 2019-08-05 16:55
SillaJen remains confident about Pexa-Vec’s value, despite trial failure by Jeong Sae-im 2019-08-05 14:49
Suspicions resurge over SillaJen execs’ stock selling before Pexa-Vec trial suspension by Jeong Sae-im 2019-08-05 11:26
Biotech shares tank amid SillaJen’s likely halt of Pexa-Vec trial by Jeong Sae-im 2019-08-02 15:45
여백
여백
여백
Back to Top